OverviewChartNewsTraderScreen

ASOS PLC/  GB0030927254  /

Turquoise
2024-05-03  5:26:36 PM Chg. +8.50 Volume Bid- Ask- High Low
358.50GBX +2.43% 5,242
Turnover(GBP): 18,732.9120		 -Bid Size: - -Ask Size: - 361.40 352.80
GlobeNewswire 05-02 Matinas BioPharma to Webcast Conference Call to Discuss First Quarter 2024 Financial Results and Pro...
GlobeNewswire 05-01 Creyon Bio and Cajal Neuroscience Announce Partnership to Develop Oligonucleotide-Based Medicines fo...
GlobeNewswire 04-30 In Vivo Efficacy of Matinas BioPharma’s Oral MAT2203 in Pulmonary Mucormycosis Published in Journal ...
GlobeNewswire 04-03 Matinas BioPharma Prices $10 Million Registered Direct Offering
GlobeNewswire 03-27 Matinas BioPharma Reports 2023 Financial Results and Provides a Business Update
GlobeNewswire 03-25 Matinas BioPharma Announces Positive in vivo Safety Data with its Oral LNC-Docetaxel Formulation
GlobeNewswire 03-22 Three Patients with Invasive Fusarium Infection in Matinas BioPharma’s Oral MAT2203 Compassionate/Ex...
GlobeNewswire 03-22 Matinas BioPharma Regains Compliance with NYSE American Continued Listing Standards
GlobeNewswire 03-06 TransCode Therapeutics To Present At 2024 RNA Leaders Europe Congress
GlobeNewswire 03-06 New Biomarker Data Add Further Evidence Supporting the Potential Benefit of SPINRAZA® (nusinersen) i...
GlobeNewswire 02-26 Matinas BioPharma Provides Positive Outcomes Update on the MAT2203 Compassionate/Expanded Use Access...
GlobeNewswire 02-20 Matinas BioPharma Successfully Reaches Agreement with FDA for a Single Phase 3 Registration Trial to...
GlobeNewswire 02-08 Publicis Groupe : Full Year 2023 Results
GlobeNewswire 01-08 Denali Therapeutics Announces Key Anticipated 2024 Milestones and Priorities to Further Advance Its ...
GlobeNewswire 01-03 Matinas BioPharma to Present at Biotech Showcase 2024
GlobeNewswire 2023-12-27 Matinas BioPharma Demonstrates in vivo Biological Activity and Disease Improvement in Two Inflammato...
GlobeNewswire 2023-12-21 Matinas BioPharma Provides Update to MAT2203 Regulatory and Development Pathway Following Feedback f...
GlobeNewswire 2023-11-14 Capricor Therapeutics Reports Third Quarter 2023 Financial Results and Provides Corporate Update
GlobeNewswire 2023-11-13 ViaNautis Bio announces $25 million Series A financing to drive the next generation of genetic nanom...
GlobeNewswire 2023-11-07 Denali Therapeutics Reports Third Quarter 2023 Financial Results and Business Highlights
GlobeNewswire 2023-10-12 Marrying Form and Function, PrismHR Unveils New Unified Employee Experience (UEX)
GlobeNewswire 2023-10-12 Publicis Groupe : Third Quarter 2023 Revenue
GlobeNewswire 2023-10-10 Capricor Therapeutics Announces Late-Breaking Presentations at 28th Annual Congress of the World Mus...
GlobeNewswire 2023-10-10 GXO and ASOS Celebrate 10th Anniversary of Successful Partnership
GlobeNewswire 2023-10-06 Locanabio Announces Presentation of Preclinical Data Demonstrating an Improved Vectorized snRNA Plat...